144 related articles for article (PubMed ID: 35456292)
1. Sex Differences in Cardiovascular Prevention in Type 2: Diabetes in a Real-World Practice Database.
Ramírez-Morros A; Franch-Nadal J; Real J; Gratacòs M; Mauricio D
J Clin Med; 2022 Apr; 11(8):. PubMed ID: 35456292
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and degree of cardiovascular risk factor control in patients with newly-diagnosed type 2 diabetes in Catalonia.
Ramírez-Morros A; Franch-Nadal J; Real J; Miró-Catalina Q; Bundó M; Vlacho B; Mauricio D
Front Endocrinol (Lausanne); 2024; 15():1339879. PubMed ID: 38390201
[TBL] [Abstract][Full Text] [Related]
3. Sex disparity persists in the prevention of cardiovascular disease in women on statin therapy compared to that in men.
Moreno-Arellano S; Delgado-de-Mendoza J; Santi-Cano MJ
Nutr Metab Cardiovasc Dis; 2018 Aug; 28(8):810-815. PubMed ID: 29754716
[TBL] [Abstract][Full Text] [Related]
4. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
[TBL] [Abstract][Full Text] [Related]
5. Gender differences in composite control of cardiovascular risk factors among patients with type 2 diabetes.
Strom Williams JL; Lynch CP; Winchester R; Thomas L; Keith B; Egede LE
Diabetes Technol Ther; 2014 Jul; 16(7):421-7. PubMed ID: 24735058
[TBL] [Abstract][Full Text] [Related]
6. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
[TBL] [Abstract][Full Text] [Related]
7. Plasma lipoprotein levels as predictors of cardiovascular death in women.
Bass KM; Newschaffer CJ; Klag MJ; Bush TL
Arch Intern Med; 1993 Oct; 153(19):2209-16. PubMed ID: 8215724
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein lipids in older people. Results from the Cardiovascular Health Study. The CHS Collaborative Research Group.
Ettinger WH; Wahl PW; Kuller LH; Bush TL; Tracy RP; Manolio TA; Borhani NO; Wong ND; O'Leary DH
Circulation; 1992 Sep; 86(3):858-69. PubMed ID: 1516198
[TBL] [Abstract][Full Text] [Related]
9. Relationship between very low low-density lipoprotein cholesterol concentrations not due to statin therapy and risk of type 2 diabetes: A US-based cross-sectional observational study using electronic health records.
Feng Q; Wei WQ; Chung CP; Levinson RT; Sundermann AC; Mosley JD; Bastarache L; Ferguson JF; Cox NJ; Roden DM; Denny JC; Linton MF; Edwards DRV; Stein CM
PLoS Med; 2018 Aug; 15(8):e1002642. PubMed ID: 30153257
[TBL] [Abstract][Full Text] [Related]
10. Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes: findings from the Dutch Diabetes Pearl cohort.
de Jong M; Oskam MJ; Sep SJS; Ozcan B; Rutters F; Sijbrands EJG; Elders PJM; Siegelaar SE; DeVries JH; Tack CJ; Schroijen M; de Valk HW; Abbink EJ; Stehouwer CDA; Jazet I; Wolffenbuttel BHR; Peters SAE; Schram MT;
BMJ Open Diabetes Res Care; 2020 Oct; 8(1):. PubMed ID: 33023896
[TBL] [Abstract][Full Text] [Related]
11. Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease.
Castañer O; Pintó X; Subirana I; Amor AJ; Ros E; Hernáez Á; Martínez-González MÁ; Corella D; Salas-Salvadó J; Estruch R; Lapetra J; Gómez-Gracia E; Alonso-Gomez AM; Fiol M; Serra-Majem L; Corbella E; Benaiges D; Sorli JV; Ruiz-Canela M; Babió N; Sierra LT; Ortega E; Fitó M
J Am Coll Cardiol; 2020 Dec; 76(23):2712-2724. PubMed ID: 33272365
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control.
Pérez A; Wägner AM; Carreras G; Giménez G; Sánchez-Quesada JL; Rigla M; Gómez-Gerique JA; Pou JM; de Leiva A
Arch Intern Med; 2000 Oct; 160(18):2756-62. PubMed ID: 11025785
[TBL] [Abstract][Full Text] [Related]
13. Sex differences in cardiovascular risk management for people with diabetes in primary care: a cross-sectional study.
de Jong M; Vos RC; de Ritter R; van der Kallen CJ; Sep SJ; Woodward M; Stehouwer CD; Bots ML; Peters SA
BJGP Open; 2019 Jul; 3(2):. PubMed ID: 31366676
[TBL] [Abstract][Full Text] [Related]
14. Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets' attainment in subjects with and without type 2 diabetes.
Morieri ML; Perrone V; Veronesi C; Degli Esposti L; Andretta M; Plebani M; Fadini GP; Vigili de Kreutzenberg S; Avogaro A
Cardiovasc Diabetol; 2021 Jul; 20(1):144. PubMed ID: 34271920
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe dyslipidemia and cardiovascular disease or risk factors for cardiovascular disease: The Women's Atorvastatin Trial on Cholesterol (WATCH).
McPherson R; Angus C; Murray P; Genest J;
Am Heart J; 2001 Jun; 141(6):949-56. PubMed ID: 11376309
[TBL] [Abstract][Full Text] [Related]
16. Age- and Gender-Related Differences in LDL-Cholesterol Management in Outpatients with Type 2 Diabetes Mellitus.
Russo G; Pintaudi B; Giorda C; Lucisano G; Nicolucci A; Cristofaro MR; Suraci C; Mulas MF; Napoli A; Rossi MC; Manicardi V
Int J Endocrinol; 2015; 2015():957105. PubMed ID: 25873960
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl.
Malave H; Castro M; Burkle J; Voros S; Dayspring T; Honigberg R; Pourfarzib R
Am J Cardiol; 2012 Sep; 110(5):662-5. PubMed ID: 22621796
[TBL] [Abstract][Full Text] [Related]
18. Serum lipid profiles and their relationship to cardiovascular disease in the elderly: the PREV-ICTUS study.
Lozano JV; Pallarés V; Cea-Calvo L; Llisterri JL; Fernández-Pérez C; Martí-Canales JC; Aznar J; Gil-Guillén V; Redón J;
Curr Med Res Opin; 2008 Mar; 24(3):659-70. PubMed ID: 18218194
[TBL] [Abstract][Full Text] [Related]
19. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
[TBL] [Abstract][Full Text] [Related]
20. Differences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl Study.
Franch-Nadal J; Mata-Cases M; Vinagre I; Patitucci F; Hermosilla E; Casellas A; Bolivar B; Mauricio D
Int J Endocrinol; 2014; 2014():131709. PubMed ID: 25328520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
